43 results on '"Socié, Gérard"'
Search Results
2. Treosulfan compared with <scp>reduced‐intensity</scp> busulfan improves allogeneic hematopoietic cell transplantation outcomes of older acute myeloid leukemia and myelodysplastic syndrome patients: Final analysis of a prospective randomized trial
3. Treosulfan compared with reduced‐intensity busulfan improves allogeneic hematopoietic cell transplantation outcomes of older acute myeloid leukemia and myelodysplastic syndrome patients: Final analysis of a prospective randomized trial
4. Graft‐versus‐host disease and late effects after hematopoietic stem cell transplantation
5. Second malignancies
6. The impact of concomitant cytogenetic abnormalities on acute myeloid leukemia with monosomy 7 or deletion 7q after HLA‐matched allogeneic stem cell transplantation
7. Eculizumab in paroxysmal nocturnal haemoglobinuria and atypical haemolytic uraemic syndrome: 10‐year pharmacovigilance analysis
8. The effect of age in patients with acquired aplastic anaemia treated with immunosuppressive therapy: comparison of Adolescents and Young Adults with children and older adults
9. Alemtuzumab vs anti-thymocyte globulin in patients transplanted from an unrelated donor after a reduced intensity conditioning
10. Anti-thymocyte globulin improves survival free from relapse and graft-versus-host disease after allogeneic peripheral blood stem cell transplantation in patients with Philadelphia-negative acute lymphoblastic leukemia: An analysis by the Acute Leukemia Wo
11. Nationwide survey on the use of horse antithymocyte globulins (ATGAM) in patients with acquired aplastic anemia: A report on behalf of the French Reference Center for Aplastic Anemia
12. Recovery of full donor chimerism with ibrutinib therapy in relapsed CLL after allogeneic stem cell transplantation
13. Assessment of human antihuman antibodies to eculizumab after long-term treatment in patients with paroxysmal nocturnal hemoglobinuria
14. Evidence of Th1, Th17 and Tc17 cells in psoriasiform chronic graft-versus-host disease
15. Impact of the source of hematopoietic stem cell in unrelated transplants: Comparison between 10/10, 9/10-HLA matched donors and cord blood
16. Outcome of patients activating an unrelated donor search for severe acquired aplastic anemia
17. Graft‐Versus‐Host Disease and Late Effects After Hematopoetic Stem Cell Transplantation
18. Immunological profile of Fanconi anemia: A multicentric retrospective analysis of 61 patients
19. Long‐term safety and efficacy of sustained eculizumab treatment in patients with paroxysmal nocturnal haemoglobinuria
20. Increase of suicide and accidental death after hematopoietic stem cell transplantation
21. Allogeneic stem cell transplantation for chronic myelomonocytic leukemia: a report from the Societe Francaise de Greffe de Moelle et de Therapie Cellulaire
22. Endothelial colony-forming cells from patients with paroxysmal nocturnal haemoglobinuria are notPIGAmutated
23. Successful use of eculizumab in a patient with post-transplant thrombotic microangiopathy
24. Incidence of liver abnormalities in Fanconi anemia patients
25. Weight-based strategy of dose administration in children using intravenous busulfan: Clinical and pharmacokinetic results
26. Allogeneic haematopoietic stem cell transplantation for myelofibrosis: a report of the Société Française de Greffe de Moelle et de Thérapie Cellulaire (SFGM‐TC)
27. correspondence: Splenectomy after allogeneic haematopoietic stem cell transplantation in patients with primary myelofibrosis
28. Coeliac disease and aplastic anaemia: a specific entity?
29. Influence of bone marrow graft B lymphocyte subsets on outcome after HLA-identical sibling transplants
30. Head and neck squamous cell carcinoma in 13 patients with Fanconi anemia after hematopoietic stem cell transplantation
31. Cardiac and cardiovascular consequences after haematopoietic stem cell transplantation
32. Influence of bone marrow nucleated red blood cell dose on outcome after allogeneic haematopoietic stem cell transplantation
33. Crypt loss, pericapillary hemorrhage, and severe gastrointestinal graft-versus-host disease
34. Second transplant with two unrelated cord blood units for early graft failure after haematopoietic stem cell transplantation
35. Effective graft-versus-leukaemia effect after allogeneic stem cell transplantation using reduced-intensity preparative regimens in Fanconi anaemia patients with myelodysplastic syndrome or acute myeloid leukaemia
36. Evidence for glycosylphosphatidylinositol (GPI)‐anchored eosinophil‐derived neurotoxin (EDN) on human granulocytes
37. Prolonged immune deficiency following allogeneic stem cell transplantation: risk factors and complications in adult patients
38. Transplantation for Fanconi's anaemia: long-term follow-up of fifty patients transplanted from a sibling donor after low-dose cyclophosphamide and thoraco-abdominal irradiation for conditioning
39. Detection of maternal cells in human fetal blood during the third trimester of pregnancy using allele‐specific PCR amplification
40. Short‐ and long‐term follow‐up of thyroid dysfunction after allogeneic bone marrow transplantation without the use of preparative total body irradiation
41. IBMTR Severity INDEX FOR GRADING ACUTE GRAFT‐VERSUS‐HOST DISEASE: RETROSPECTIVE COMPARISON WITH GLUCKSBERG GRADE
42. Potential role for low dose limited‐field radiation therapy (2 × 2 grays) in advanced low‐grade non‐Hodgkin's lymphomas
43. Prognostic impact of number of induction courses to attain complete remission in patients with acute myeloid leukemia transplanted with either a matched sibling or human leucocyte antigen 10/10 or 9/10 unrelated donor: An Acute Leukemia Working Party European Society for Blood and Marrow Transplantation study.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.